Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AGS-PSCA: a candidate for clinical trials in prostate, pancreatic cancers

April 27, 2005

PRO-001 a novel therapeutic strategy for multiple myeloma

April 26, 2005

Genmab reaches SPA agreement for HuMax-CD4 pivotal study

April 22, 2005

New phase II safety study for BLP25 Liposome Vaccine

April 22, 2005

CHIR-12.12 enters phase I

April 22, 2005

Avastin improves progression-free survival in phase III breast cancer study

April 18, 2005

GCAN-101 under evaluation in phase II study

April 14, 2005

Japanese manufacturing approval for tocilizumab for Castleman's disease

April 13, 2005

AustCancer submits DMF for GPI-0100

April 13, 2005

CT-011 completes phase I study in advanced hematological malignancies

April 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...